Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Subordinate Voting Shares (as converted)	Share Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Earnings (Deficit)	Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2022		339,983,374
Beginning balance at Dec. 31, 2022	$ 1,341,550		$ 1,665,957	$ (8)	$ (324,399)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		117,948
Share-based compensation	506		506
Issuance of shares to relieve liability obligations, net (in shares)		603,396
Issuance of shares to relieve liability obligations, net	3,653		3,653
Foreign Currency Translation Adjustment	(1)			(1)
Contingent consideration & other adjustments to purchase accounting (in shares)		1,625,546
Net Loss	(9,237)				(9,237)
Ending balance (in shares) at Mar. 31, 2023		342,330,264
Ending balance at Mar. 31, 2023	1,336,471		1,670,116	(9)	(333,636)	0
Beginning balance (in shares) at Dec. 31, 2023		344,074,096
Beginning balance at Dec. 31, 2023	1,240,080		1,681,840	(13)	(441,747)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		57,872
Share-based compensation	3,643		3,643
Foreign Currency Translation Adjustment	15			15
Contingent consideration & other adjustments to purchase accounting (in shares)		31,181
Net Loss	(4,822)				(4,822)
Ending balance (in shares) at Mar. 31, 2024		344,163,149
Ending balance at Mar. 31, 2024	$ 1,238,916		$ 1,685,483	$ 2	$ (446,569)	$ 0